Does LEVOMILNACIPRAN Cause Onychomadesis? 129 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Onychomadesis have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 9.4% of all adverse event reports for LEVOMILNACIPRAN.
129
Reports of Onychomadesis with LEVOMILNACIPRAN
9.4%
of all LEVOMILNACIPRAN reports
129
Deaths
79
Hospitalizations
How Dangerous Is Onychomadesis From LEVOMILNACIPRAN?
Of the 129 reports, 129 (100.0%) resulted in death, 79 (61.2%) required hospitalization, and 80 (62.0%) were considered life-threatening.
Is Onychomadesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 129 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Onychomadesis?
ADALIMUMAB (797)
METHOTREXATE (785)
RITUXIMAB (722)
TOCILIZUMAB (721)
ABATACEPT (703)
INFLIXIMAB (682)
SECUKINUMAB (678)
LEFLUNOMIDE (667)
GOLIMUMAB (660)
HYDROXYCHLOROQUINE (660)
Which LEVOMILNACIPRAN Alternatives Have Lower Onychomadesis Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE